Systemic steroids for acute gout
References
Additional references
Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 1988;41:237‐42.. Journal of clinical epidemiology 1988;41:237‐42.
Ahern MJ, Reid C, Gordon TP, McCredie M, Brooks PM, Jones M. Does colchicine work? The results of the first controlled study in acute gout. Australian and New Zealand journal of medicine 1987;17(3):301‐304. [MEDLINE: 45]
Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. The Journal of rheumatology 1993;20(1):111‐113. [MEDLINE: 51]
Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising?. The Journal of rheumatology 2002;29(11):2403‐2406. [MEDLINE: 1]
Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis and rheumatism 2004;50(8):2400‐2414. [MEDLINE: 2]
Chris Cates www.nntonline.com. Visual Rx ‐ NNT Calculator. Chris Cates www.nntonline.com, 2003.
Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37‐46. [Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37‐46. Cohen 1960 Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37‐46. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37‐46.]
Conaghan PG, Day RO. Risks and benefits of drugs used in the management and prevention of gout. Drug safety : an international journal of medical toxicology and drug experience 1994;11(4):252‐258. [MEDLINE: 47]
Fam AG. Managing problem gout. Annals of the Academy of Medicine, Singapore 1998;27(1):93‐99. [MEDLINE: 46]
Fam AG. Gout in the elderly. Clinical presentation and treatment. Drugs aging 1998;13(3):229‐243. [MEDLINE: 54]
Groff GD, Franck WA, Raddatz DA. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Seminars in arthritis and rheumatism 1990;19(6):329‐336. [MEDLINE: 50]
Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005} In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd..
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58.
Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non‐steroidal anti‐inflammatory drugs: systematic review. British Medical Journal 2004;329(7472):948. [MEDLINE: 42]
Janssens HJEM, Van de Lisdonk EH, Bor H, Van den Hoogen HJM, Janssen M. Gout, just a nasty event or a cardiovascular signal? A study from primary care. Family Practice 2003;20:413‐6.
Maccagno A, Di Giorgio E, Romanowicz A. Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout. Current medical research and opinion 1991;12(7):423‐429. [MEDLINE: 39]
Moens HJ, van Croonenborg JJ, Al MJ, van den Bemt PM, Lourens J, Numans ME. [Guideline 'NSAID use and the prevention of gastric damage']. Nederlands tijdschrift voor geneeskunde 2004;148(13):604‐608. [MEDLINE: 43]
Morris I, Varughese G, Mattingly P. Colchicine in acute gout. British Medical Journal 2003;327(7426):1275‐1276. [MEDLINE: 48]
Perez‐Ruiz F, Calabozo M, Herrero‐Beites AM, Garcia‐Erauskin G, Pijoan JI. Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 2000;86(3):287‐291. [MEDLINE: 44]
Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. International journal of epidemiology 2002;31(1):150‐153. [MEDLINE: 36]
Schlesinger N. Management of acute and chronic gouty arthritis: present state‐of‐the‐art. Drugs 2004;64(21):2399‐2416. [MEDLINE: 3]
Schumacher HR. Crystal‐induced arthritis: an overview. The American journal of medicine 1996;100(2A):46S‐52S. [MEDLINE: 55]
Schumacher HR, Jr, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, Tate GA, Molina J. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. British Medical Journal 2002;324(7352):1488‐1492. [MEDLINE: 41]
Shrestha M, Morgan DL, Moreden JM, Singh R, Nelson M, Hayes JE. Randomized double‐blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis. Annals of emergency medicine 1995;26(6):682‐686. [MEDLINE: 40]
Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. The Journal of rheumatology 1994;21(7):1325‐1327. [MEDLINE: 52]
Sturge RA, Scott JT, Hamilton EB, Liyanage SP, Dixon AS, Davies J, Engler C. Multicentre trial of naproxen and phenylbutazone in acute gout. Annals of the rheumatic diseases 1977;36(1):80‐82. [MEDLINE: 38]
Terkeltaub RA. Clinical practice. Gout. New England Journal of Medicine 2003;349(17):1647‐1655. [MEDLINE: 4]
Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, et al. Evidence Based Rheumatology. BMJ Books, 2004.
Van de Lisdonk EH, Van den Bosch WJHM, Huygen FJA, Lagro‐Janssen ALM. Diseases in general practice. Ziekten in de huisartspraktijk. 4th Edition. Maarssen: Elsevier, 2003.
Van der Linden MW, Wetsert GP, De Bakker DH, Schellevis FG. Ilness and disease in the community and family practice [Klachten en aandoeningen in de bevolking en in de huisartspraktijk]. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk. Utrecht, Bilthoven: NIVEL, Rijksinstituut voor Volksgezondheid en Milieu, 2004 (available from: http://www.nivel.nl/pdf/ns2_rapport1.pdf). [MEDLINE: http://www.nivel.nl/pdf/ns2_rapport1.pdf; http://www.nivel.nl/pdf/ns2_rapport1.pdf]
Werlen D, Gabay C, Vischer TL. Corticosteroid therapy for the treatment of acute attacks of crystal‐induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs. Revue du rhumatisme (English ed ) 1996;63(4):248‐254. [MEDLINE: 53]
Wise CM, Agudelo CA. Gouty arthritis and uric acid metabolism. Current opinion in rheumatology 1996;8(3):248‐254. [MEDLINE: 49]
